Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06749288 · ClinicalTrials.gov registry record · NA
Radicle Revive 24: A Study of Health and Wellness Products on Menopausal Health and Related Health Outcomes
A NA study of Depression and Anxiety, sponsored by Radicle Science.
- Completed
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT06749288: Completed NA study of Depression and Anxiety, sponsored by Radicle Science.
NCT06749288 is a NA study of Depression and Anxiety that has completed, run by Radicle Science. The registered enrollment target is 500 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06749288, a NA study of Depression and Anxiety, has completed, sponsored by Radicle Science.
- COMPLETED
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized, double-blind, placebo-controlled, direct-to-consumer trial assessing the impact of health and wellness products on hormonal health and associated health outcomes in women with menopausal health issues
Primary Outcome
Mean difference in anxiety score as assessed by PROMIS Anxiety 4A (scale 4-20; with higher scores corresponding to more severe anxiety)
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Radicle Revive Placebo Control Form 4.1
- DIETARY_SUPPLEMENT Radicle Revive Active Study Product 4.1 Usage
Study Locations (1)
California
- Radicle Science, Inc - Del Mar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2025-01-01 |
| Est. Completion | 2025-07-01 |
| Phase | NA |
What the finished NCT06749288 record still lists
NCT06749288 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (36% lower).
The record links to 7 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Radicle Revive Placebo Control Form 4.1 is the first listed.
NCT06749288 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06749288 about?
NCT06749288 is a clinical study titled "Radicle Revive 24: A Study of Health and Wellness Products on Menopausal Health and Related Health Outcomes". A randomized, double-blind, placebo-controlled, direct-to-consumer trial assessing the impact of health and wellness products on hormonal health and associated health outcomes in women with menopausal health issues
What is the current status of trial NCT06749288?
This trial is currently completed. It is a NA study. The enrollment target is 500 participants. The study started on 2025-01-01. Estimated completion is 2025-07-01.
What conditions does trial NCT06749288 study?
This clinical trial studies the following conditions: Depression, Anxiety, Fatigue, Sleep Disturbance, Menopause.
What interventions are being tested in trial NCT06749288?
The interventions under investigation include: Radicle Revive Placebo Control Form 4.1 (DIETARY_SUPPLEMENT), Radicle Revive Active Study Product 4.1 Usage (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06749288?
This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06749288 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06749288's enrollment target sits among peer trials
500 79th of 679 higher than 592 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy